Cancel
Michelle C. Werner
Chief Executive Officer & Director
@
Alltrna
pf1v881@y8x0b02.6iv
Sign up to see email
Known information
- Holds a B.A. in biology & anthropology from the University of Pennsylvania
- Earned an MBA from the London Business School
- Completed an Executive Education program for Women on Boards at Harvard Business School in 2018
- Previously served as Worldwide Franchise Head, Solid Tumors at Novartis Oncology
- Was a senior leader at AstraZeneca, including roles as Global Franchise Head in Hematology and Head of US Oncology
- Worked at Bristol Myers Squibb for 10 years in various roles, including sales, marketing, and market access
- Started her professional career in R&D, working hands-on with patients at the Oncology Clinical Trials Unit at Harvard Medical School
- Is a wife and mother to three children
- Is a member of the rare disease community
- Currently serving a Board appointment for the non-profit organization Rare Disease Renegades
About Alltrna
Alltrna is the world's first tRNA platform company, pioneering tRNA therapeutics to potentially treat thousands of diseases by targeting premature stop codons.
Report inaccurate information
